Studies have shown that prostate cancer cells transfer pyruvate kinase M2 (PKM2) to bone marrow stromal cells (BMSCs) through exosomes, upregulating CXCL12 production to “educate” the bone marrow microenvironment and create pre-metastatic niches. This evidence concerns the gene PKM and prostate carcinoma.